BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30451190)

  • 1. Periocular topotecan for vitreous seeds in retinoblastoma.
    Sthapit PR; Rao R; Honavar SG
    Indian J Ophthalmol; 2018 Dec; 66(12):1833-1838. PubMed ID: 30451190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma.
    Rao R; Honavar SG; Sharma V; Reddy VAP
    Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
    JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
    Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periocular topotecan for intraocular retinoblastoma.
    Mallipatna AC; Dimaras H; Chan HS; Héon E; Gallie BL
    Arch Ophthalmol; 2011 Jun; 129(6):738-45. PubMed ID: 21670340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
    Shields CL; Manjandavida FP; Arepalli S; Kaliki S; Lally SE; Shields JA
    JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
    J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
    Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
    J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
    Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
    Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.
    Francis JH; Iyer S; Gobin YP; Brodie SE; Abramson DH
    Ophthalmology; 2017 Oct; 124(10):1548-1555. PubMed ID: 28545735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma.
    Kiratli H; Koç I; Öztürk E; Varan A; Akyüz C
    Jpn J Ophthalmol; 2020 Jul; 64(4):351-358. PubMed ID: 32447585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
    Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
    Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye salvage in diffuse anterior retinoblastoma using systemic chemotherapy with periocular and intravitreal topotecan.
    Rao R; Honavar SG; Mulay K; Reddy VAP
    J AAPOS; 2018 Jun; 22(3):235-237.e2. PubMed ID: 29698780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
    Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
    Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial Chemotherapy as Primary Treatment for Cavitary Retinoblastoma: Excellent Response in Eight Tumors.
    Zheng Y; Froehler MT; Friedman DL; Daniels AB
    Ophthalmol Retina; 2021 May; 5(5):479-485. PubMed ID: 32853834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
    Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.